I study cytokine/interferon signaling, macrophage–fibroblast states, and immune‑metabolic crosstalk in kidney disease and viral infection, pinpointing druggable nodes and biomarkers to guide anti‑fibrotic, anti‑inflammatory, and antiviral therapies.